BackEnvista Holdings Overview

Envista Holdings EBIT

Latest ebit for NVST: $280M, below the Healthcare sector average of $23B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$83.10M
79.48% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$277.80M
72.76% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Envista Holdings (NVST) FAQ

Envista Holdings (NVST) currently reports a EBIT of $280M as of June 2026. That compares with $160M in the prior-year period — up 72.8% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Envista Holdings's EBIT history and peer comparisons.

Envista Holdings's EBIT increased from $160M to $280M — a 72.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Envista Holdings's EBIT of $280M is lower than the Healthcare sector average of $23B. That is roughly 98.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Envista Holdings reported $280M in EBIT as of June 2026. That compares with $160M in the prior-year period — up 72.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $280M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Envista Holdings, and consider following NVST for alerts when major investors trade the stock.